Systematic Profiling of Alternative Splicing for Sarcoma Patients Reveals Novel Prognostic Biomarkers Associated with Tumor Microenvironment and Immune Cells

BACKGROUND: Alternative splicing (AS) events is a novel biomarker of tumor prognosis, but the role of AS events in sarcoma patients remains unclear. MATERIAL/METHODS: RNA-seq and clinicopathologic data of the sarcoma cohort were extracted from the TCGA database and data on AS events were downloaded...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Chuan, Wang, Yuanhe, Liu, Chuan, Shen, Rui, Chen, Bo, Sun, Kang, Rao, Huili, Ye, Lin, Ye, Jianjun, Tian, Shaoqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2020
Materias:
Database Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388651/
https://www.ncbi.nlm.nih.gov/pubmed/32683393
http://dx.doi.org/10.12659/MSM.924126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388651/
https://www.ncbi.nlm.nih.gov/pubmed/32683393
http://dx.doi.org/10.12659/MSM.924126

Ejemplares similares